| Turkey | Austria | Spain | |
| Percutaneous nephrolithotomy (PCNL) | from $4,000 | from $15,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Percutaneous nephrolithotomy (PCNL) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Percutaneous nephrolithotomy (PCNL) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Percutaneous nephrolithotomy (PCNL) journey.
Specializes in kidney and urinary tract endoscopic stone crushing treatment – Dr. Erguney brings decades of focused urology expertise to PCNL procedures.
Associate Professor Ozkan Onuk specializes in urology with extensive research in minimally invasive techniques at Yeni Yüzyıl University.
Specializes in RIRS (Laser Stone Breaking in the Kidney) and complex urological surgeries at Büyük Anadolu Hospitals.
Prof. Dr. Kadir Önem is a Professor of Urology at Medical Park Hospital in Samsun. He earned his MD and completed his urology residency at Istanbul University. He then completed a postdoctoral fellowship at Baylor College of Medicine in neuro-urology, reconstructive urology, and urologic oncology. He treats complex neuro-urological and reconstructive cases in adults and children. He has developed surgical techniques.
He is a principal investigator in several international Phase III–IV trials on neurogenic bladder and bladder cancer. He has more than 70 publications and book chapters. He serves as a reviewer for multiple journals.
Leadership and affiliations: President, Turkish Urological Association – Western Black Sea Branch (2025). ISCoS Prevention Committee (2025). EAU Neurourology Group (2023–2025). ICS Neurourology Committee (2023–2025). INUS Board (2023). Awards: TUA (2016, 2017, 2020, 2022) and ICS (2020).